Patent · US Active

PD-L1 binding fibronectin type III domains

US10597438B2 · kind B2 · utility

9Cited by
21References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 13, 2017
Grant dateMar 24, 2020
Priority date
Expiry dateDec 13, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/61
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

FN3 domains that specifically bind to PD-L1, their conjugates, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making and using them are useful in therapeutic and diagnostic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.